(224) BAP-1 Inactivated Melanocytic Tumor (BIMT) with retained BAP-1 immunohistochemical staining: A potential pitfall

Lindsay Gunnell, MD; Victoria Wilk, MS, BA; Oliver Chang, MD & Michi Shinohara, MD

ASDP 61st Annual Meeting

Part of: Poster Defense Session and Mentorship Awards (hidden)